Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: Compartmental model investigation and mathematical analysis

Molecular Imaging

Volumn 1, Issue 3, 2002, Pages 151-159

  Wells, Joanne M ^a   Mankoff, David A ^a,c   Muzi, Mark ^a   O'Sullivan, Finbarr ^b   Eary, Janet F ^a   Spence, Alexander M ^a   Krohn, Kenneth A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Brain tumors; Kinetic modeling; PET; Proliferation; 11 Thymidine

Indexed keywords

BRAIN; COMPUTER SIMULATION; DNA; DRUG THERAPY; MEDICAL IMAGING; METABOLISM; PARAMETER ESTIMATION; TISSUE;

CELLULAR PROLIFERATION;

ONCOLOGY;

CARBON; DIAGNOSTIC AGENT; DNA; THYMIDINE;

ACTIVE TRANSPORT; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; BRAIN TUMOR; CELL DIVISION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; MATHEMATICS; METABOLISM; PATHOLOGY; SCINTISCANNING;

BIOLOGICAL TRANSPORT, ACTIVE; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CELL DIVISION; DNA, NEOPLASM; HUMANS; MATHEMATICS; MODELS, NEUROLOGICAL; THYMIDINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0013110356     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535002760235454     Document Type: Article

References (35)

1. Cleaver JE (1967). Thymidine metabolism and cell kinetics. Frontiers Biol. 6:43-100.
2. 3H labeling index in human solid tumors. Cancer Res. 34:1376-1380.
3. Tew KD, Taylor DM (1978). The relationship of thymidine metabolism to the use of fractional incorporation as a measure of DNA synthesis in tissue proliferation. Eur J Cancer. 14:153-168.
4. Molnar P, Groothuis D, Blasberg R, Zaharko D, Owens E, Fenstermacher J (1984). Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors. J Neurochem. 43:421-432.
5. Livingston RB, Hart JS (1977). The clinical applications of cell kinetics in cancer therapy. Annu Rev Pharmacol Toxicol. 17:529-543.
6. Phillips RM, Bibby MC, Double JA (1990). A critical appraisal of the predictive value of in vitro chemosensitivity assays. J Natl Cancer Inst. 82:1457-1468.
7. Mankoff DA, Dehdashti F, Shields AF (2000). Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. Neoplasia. 2:71-88.
8. Krohn KA, Mankoff DA, Eary JF (2001). Imaging cellular proliferation as a measure of response to therapy. J Clin Pharmacol. 41:96S-103S.
9. Shields AF, Lim K, Grierson J, Link J, Krohn KA (1990). Utilization of labeled thymidine in DNA synthesis: Studies for PET. J Nucl Med. 31:337-342.
10. Shields AF, Graham MM, Kozawa SM, Kozell LB, Link JM, Swenson ER, Spence AM, Bassingthwaighte JB, Krohn KA (1992). Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. J Nucl Med. 33:581-584.
11. Goethals P, van Eijkeren M, Lodewyck W, Dams R (1995). Measurement of [Methyl-carbon-11]-thymidine and its metabolites in head and neck tumors. J Nucl Med. 36:880-882.
12. Shields AF, Mankoff D, Graham MM, Zheng M, Kozawa SM, Link JM, Krohn KA (1996), Analysis of 2-[C-11]-thymidine blood metabolites in PET imaging. J Nucl Med. 37:290-296.
13. Mankoff DA, Shields AF, Graham MM, Link JM, Muzi M, Eary JF, Krohn KA (1998). Kinetic analysis of 2-[C-11]-thymidine PET imaging studies: Compartmental model and mathematical analysis. J Nucl Med. 39:1043-1055.
14. 11C]-thymidine PET imaging studies: Validation studies. J Nucl Med. 40:614-624.
15. Cornford EM, Oldendorf WH (1975). Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim Biophys Acta. 394:211-219.
16. Curnes JT, Laster DW, Ball MR, Moody DM, Witcofski R (1986). MRI of radiation injury to the brain. Am J Roentgenol. 147:119-124.
17. 11C]-thymidine PET imaging studies of malignant brain tumors: Preliminary patient results. Mol Imaging. 1:145-150.
18. Goldman D, Bowen D, Gewirtz DA (1981). Some considerations in the experimental approach to distinguishing between membrane transport and intracellular disposition of antineo-plastic agents, with specific reference to fluorodeoxyuridine, actinomycin D, and methotrexate. Cancer Treatment Rep. 65:43-56.
19. Yalowich JC, Goldman ID (1984). Analysis of the inhibitory effects of VP-16-213 (Etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro. Cancer Res. 44:984-989.
20. Taheri MR, Wickremasinghe RG, Hoffbrand AV (1981). Alternative metabolic fates of thymine nucleotides in human cells. Biochem J. 194:451-461.
21. Plagemann PG, Erbe J (1972). Thymidine transport by cultured Novikoff hepatoma cells and uptake by simple diffusion and relationship to incorporation into deoxyribonucleic acid. J Cell Biol. 55:161-178.
22. 2 and Positron Emission Tomography. J Cereb Blood Flow Metab. 4:458-465.
23. 2 and Positron Emission Tomography. J Cereb Blood Flow Metab. 4:8-16.
24. Kuebbing D, Werner R (1975). A model for compartmentation of de novo and salvage thymidine nucleotide pools in mammalian cells. Proc Natl Acad Sci USA. 72:3333-3336.
25. Nicander B, Reichard P (1983). Dynamics of pyrimidine deoxynucleoside triphosphate pools in relationship to DNA synthesis in 3T6 mouse fibroblasts. Proc Natl Acad Sci USA. 80:1347-1351.
26. Reichard P (1985). Ribonucleotide reductase and deoxyribonucleotide pools. Basic Life Sci. 31:33-45.
27. Wohlhueter RM, Marz R, Graff JC, Plagemann PG (1976). The application of rapid kinetic techniques to the transport of thymidine and 3-O-methylglucose into mammalian cells in suspension culture. J Cell Physiol. 89:605-612.
28. Shields AF, Mankoff DA, Link JM, Graham MM, Eary JF, Kozawa SM, Zheng M, Lewellen B, Lewellen TK, Grierson JR, Krohn KA (1998). Carbon-11-thymidine and FDG to measure therapy response. J Nucl Med. 39:1757-1762.
29. Eary JF, Mankoff DA, Spence AM, Berger MS, Olshen A, Link JM, O'Sullivan F, Krohn KA (1999). Cancer Res. 59:615-621.
30. 2. J Cereb Blood Flow Metab. 7:709-719.
31. Lockwood AH, Finn RD (1982). [C-11]-carbon dioxide fixation and equilibration in rat brain: Effects on acid-base measurements. Neurology. 32:451-454.
32. 2 into the acid-labile, the acid-soluble, the lipid, the protein and the nucleic acid fractions of rat brain tissue. Acta Physiol Scand. 64:182-192.
33. Press WH, Flannery BP, Teukolsky SA, Vetterling WT (1988). Numerical Recipes in C. New York: Cambridge University Press.
34. Graham MM (1995). Kinetic evaluation using sensitivity functions and correlation matrices. J Nucl Med. 36:268P.
35. Bassingthwaighte JB, Chaloupka M (1984). Sensitivity functions in the estimation of parameters of cellular exchange. Fed Proc. 43:181-184.